These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37760559)

  • 21. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
    Lim YJ; Song C; Jeon SH; Kim K; Chie EK
    Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative presacral electron boost following preoperative chemoradiation in T3-4Nx rectal cancer: initial local effects and clinical outcome analysis.
    Calvo FA; Gómez-Espí M; Díaz-González JA; Alvarado A; Cantalapiedra R; Marcos P; Matute R; Martínez NE; Lozano MA; Herranz R
    Radiother Oncol; 2002 Feb; 62(2):201-6. PubMed ID: 11937247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer.
    Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH; Kim H; Keum KC; Ahn JB
    J Surg Oncol; 2009 Jul; 100(1):1-7. PubMed ID: 19418495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of pathologic nodal status on survival following neoadjuvant chemoradiation for locally advanced rectal cancer.
    Hernandez JM; Clark W; Weber J; Fulp WJ; Lange L; Shibata D
    Int J Colorectal Dis; 2014 Sep; 29(9):1061-8. PubMed ID: 24970021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.
    Shia J; McManus M; Guillem JG; Leibold T; Zhou Q; Tang LH; Riedel ER; Weiser MR; Paty PB; Temple LK; Nash G; Kolosov K; Minsky BD; Wong WD; Klimstra DS
    Am J Surg Pathol; 2011 Jan; 35(1):127-34. PubMed ID: 21164296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-week Course of Preoperative Radiotherapy for Locally Advanced Rectal Adenocarcinoma: 8 Years' Experience in a Single Institute.
    Zhu XG; Li JL; Li XF; Li YH; Ni QY; Wang L; Zhang SW; Gu J; Cai Y; Lin C
    Am J Clin Oncol; 2017 Jun; 40(3):266-273. PubMed ID: 25503430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
    Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M;
    Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation.
    Dudani S; Marginean H; Gotfrit J; Tang PA; Monzon JG; Dennis K; Kennecke HF; Powell ED; Babak S; Cheung WY; Vickers MM
    Dis Colon Rectum; 2021 Dec; 64(12):1471-1478. PubMed ID: 34657078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
    Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim TH; Chang HJ; Kim DY; Jung KH; Hong YS; Kim SY; Park JW; Oh JH; Lim SB; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1158-65. PubMed ID: 19800178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy.
    Huang XZ; Gao P; Song YX; Sun JX; Chen XW; Zhao JH; Ma B; Wang J; Wang ZN
    Oncotarget; 2016 Apr; 7(15):19643-53. PubMed ID: 26910371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.
    Wei J; Huang R; Guo S; Zhang X; Xi S; Wang Q; Chang H; Wang X; Xiao W; Zeng Z; Gao Y
    Cancer Manag Res; 2018; 10():5219-5225. PubMed ID: 30464619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation.
    Deidda S; Elmore U; Rosati R; De Nardi P; Vignali A; Puccetti F; Spolverato G; Capelli G; Zuin M; Muratore A; Danna R; Calabrò M; Guerrieri M; Ortenzi M; Ghiselli R; Scabini S; Aprile A; Pertile D; Sammarco G; Gallo G; Sena G; Coco C; Rizzo G; Pafundi DP; Belluco C; Innocente R; Degiuli M; Reddavid R; Puca L; Delrio P; Rega D; Conti P; Pastorino A; Zorcolo L; Pucciarelli S; Aschele C; Restivo A
    JAMA Surg; 2021 Dec; 156(12):1141-1149. PubMed ID: 34586340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?
    Fernandez LM; Figueiredo NL; Habr-Gama A; São Julião GP; Vieira P; Vailati BB; Nasir I; Parés O; Santiago I; Castillo-Martin M; Carvalho C; Parvaiz A; Perez RO
    Dis Colon Rectum; 2020 Aug; 63(8):1053-1062. PubMed ID: 32692070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome.
    Jalilian M; Davis S; Mohebbi M; Sugamaran B; Porter IW; Bell S; Warrier SK; Wale R
    J Gastrointest Oncol; 2016 Aug; 7(4):603-8. PubMed ID: 27563451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.
    Estrella JS; Rashid A; Fleming JB; Katz MH; Lee JE; Wolf RA; Varadhachary GR; Pisters PW; Abdalla EK; Vauthey JN; Wang H; Gomez HF; Evans DB; Abbruzzese JL; Wang H
    Cancer; 2012 Jan; 118(1):268-77. PubMed ID: 21735446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancer.
    Wagner J; Simon R; Büchler JW; Kirchhoff F; Kehl V; Retz M; Gschwend JE; Sauter A; Horn T
    World J Urol; 2023 Jan; 41(1):101-107. PubMed ID: 36269368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
    Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
    Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving role of neoadjuvant therapy in rectal cancer.
    Schrag D
    Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.